NorthWest Biotherapeutics Inc (NWBO)

[Horseb4CarT]

Very interesting and hoping my bias as a long time long isn’t deluding me, I am thinking (IMHO) the following:

1) would BP do a trial with Dcvax-L if dcvax was likely not to be approved? IMHO no

2) if the trial branches are Dcvax and Dcvax + Keytruda, doesn’t that position Dcvax like a SOC to compare the efficacy of Keytruda+Dcvax against? IMHO yes however my bias may particularly be affecting my judgement.

Your thoughts please?